Trials / Completed
CompletedNCT05058339
Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 223 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study assesses the level of distress felt by cancer patients due to the coronavirus disease 2019 (COVID-19) pandemic. Researchers also want to learn if patients prefer to receive supportive care (palliative care) in person or through telemedicine (visits by phone or video call, such as Zoom). Information from this study may help doctors better understand how COVID-19 has affected patients with advanced cancer, patients' perceptions of telehealth, and may help clinicians tailor care to patients' needs during the pandemic.
Detailed description
PRIMARY OBJECTIVES: I. Assess advanced cancer patients' level of distress due to the COVID-19 pandemic. II. Assess patients' overall preference towards palliative telemedicine vs in person visits during the COVID-19 pandemic. SECONDARY OBJECTIVES: I. Assess associations between patient characteristics and perceptions of overall distress due to the COVID-19 pandemic. II. Assess associations between patient characteristics and their attitudes and beliefs towards palliative telemedicine during the COVID-19 pandemic. III. Compare the attitudes and beliefs towards palliative telemedicine between patients who completed visits via video vs telephone. OUTLINE: Patients complete survey over 20 minutes.
Conditions
- Advanced Malignant Solid Neoplasm
- COVID-19 Infection
- Hematopoietic and Lymphoid Cell Neoplasm
- Locally Advanced Malignant Solid Neoplasm
- Metastatic Malignant Solid Neoplasm
- Recurrent Hematologic Malignancy
- Recurrent Malignant Solid Neoplasm
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Survey Administration | Complete survey |
Timeline
- Start date
- 2021-04-27
- Primary completion
- 2024-09-06
- Completion
- 2024-09-06
- First posted
- 2021-09-27
- Last updated
- 2024-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05058339. Inclusion in this directory is not an endorsement.